Приказ основних података о документу

dc.creatorMilenković, Milan
dc.creatorRašević, Marija
dc.creatorOtašević, Biljana
dc.creatorZečević, Mira
dc.creatorMalenović, Anđelija
dc.creatorProtić, Ana
dc.date.accessioned2021-10-12T10:38:56Z
dc.date.available2021-10-12T10:38:56Z
dc.date.issued2022
dc.identifier.issn0731-7085
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/3977
dc.description.abstractNowadays, method development is strongly focused on reducing time needed for method development and execution. This subject specially concerns gradient elution methods regarding the usual need for trouble shooting assistance with uncertain outcome during the method transfer from one laboratory to another. One of the main reasons for this situation is the dwell volume difference between HPLC systems. Therefore, the aim of this study was to propose a novel method development methodology that would integrate the dwell volumes differences in the optimization process. The proposed approach could be quite useful in industry that has insight in HPLC instruments planned to be used during the method life cycle. It was tested on the model mixture consisting of dabigatran etexilate mesylate and its nine impurities by use of perimental design methodology. Three different (U)HPLC instruments with high dwell volume differences were selected to challenge the methodology. Plan of experiments was defined with Plackett-Burman design for screening phase and D-optimal design for optimization phase. Initial and final amount of organic modifier, time of the gradient elution and pH value of the aqueous phase were selected as variables nificant for the gradient programme profile and included in the optimization stage along with dwell volume values. The separation criteria s between critical peak pairs was selected as output for method optimization while indirect modelling together with Monte Carlo simulations enabled selection of optimal and robust chromatographic conditions. They included 24% (v/v) of initial amount of acetonitrile, 54% (v/v) of the final amount of acetonitrile, 15 min of gradient elution run time and pH value equal to 4.9. The proposed method was successfully validated, met all validation criteria and thus proved its utility.
dc.publisherElsevier B.V.
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//
dc.rightsrestrictedAccess
dc.sourceJournal of Pharmaceutical and Biomedical Analysis
dc.subject(U)HPLC
dc.subjectDesign of experiments
dc.subjectDwell volume
dc.subjectGradient elution method
dc.subjectMethod optimization
dc.subjectMethod transfer
dc.titleGeneric approach in a gradient elution HPLC method development that enables troubleshooting free method transfer
dc.typearticle
dc.rights.licenseARR
dcterms.abstractЗечевић, Мира; Миленковић, Милан; Оташевић, Биљана; Рашевић, Марија; Маленовић, Aнђелија; Протић, Aна; Генериц аппроацх ин а градиент елутион ХПЛЦ метход девелопмент тхат енаблес троублесхоотинг фрее метход трансфер;
dc.citation.volume207
dc.citation.rankM21
dc.identifier.wos000706129700009
dc.identifier.doi10.1016/j.jpba.2021.114367
dc.identifier.scopus2-s2.0-85116113013
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу